JP Patent

JP7377679B2 — がん治療のためのｋｒａｓｇ１２ｃ阻害剤及び１種以上の薬学的に活性な追加の薬剤を含む併用療法

Assigned to アムジエン・インコーポレーテツド · Expires 2023-11-10 · 3y expired

What this patent protects

Patent listed against Lumakras.

Drugs covered by this patent

Patent Metadata

Patent number
JP7377679B2
Jurisdiction
JP
Classification
—
Expires
2023-11-10
Drug substance claim
No
Drug product claim
No
Assignee
アムジエン・インコーポレーテツド
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.